PATRYS LIMITED - Announcements

Market Cap $18.51M Add to my watchlist

Healthcare Biotechnology

Patrys Limited is an Australia-based company, which is focused on the development of its... Patrys Limited is an Australia-based company, which is focused on the development of its deoxymab platform of cell-penetrating antibodies as therapies for a range of different cancers. The Company's deoxymab platform is based on the deoxymab 3E10 antibody that was identified as an autoantibody in a mouse model of the human disease systemic lupus erythematosus. It has developed two humanized forms of deoxymab 3E10, both of which have improved activity over the original deoxymab 3E10 antibody: PAT-DX1, which is a dimer (two joined subunits) of the short chain from the binding domain of deoxymab 3E10, and PAT-DX3, which is a full-sized Immunoglobulin G antibody. Deoxymabs, such as PAT-DX1 and PAT-DX3, can be used to target nanoparticles carrying a payload of anti-cancer drugs specifically to tumors. Its PAT-DX1- nanoparticles (NP) pipeline involves using its PAT-DX1 to develop a new drug based on the targeted delivery of NP carrying therapeutic payloads to the inside of cancer cells.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

PAB	Chairman's Address and CEO Presentation to 2021 AGM		05/11/21	1.2MB	Share
PAB	Application for quotation of securities - PAB		04/11/21	24.75KB	Share
PAB	Letter to Optionholders - Entitlement Offer		01/11/21	192.97KB	Share
PAB	Notice under Section 708AA(2)(F) - Entitlement Offer		01/11/21	208.7KB	Share
PAB	Investor Presentation		01/11/21	5.06MB	Share
PAB	Proposed issue of securities - PAB		01/11/21	38.75KB	Share
PAB	$7.8M Capital Raising	PRICE SENSITIVE	01/11/21	221.31KB	Share
PAB	Change of Company Secretary		29/10/21	144.24KB	Share
PAB	Trading Halt	PRICE SENSITIVE	28/10/21	252.57KB	Share
PAB	Appendix 4C - Quarterly - 30 September 2021	PRICE SENSITIVE	20/10/21	399.01KB	Share
PAB	Patrys proof of concept ADC significantly increases survival	PRICE SENSITIVE	18/10/21	268.44KB	Share
PAB	Notice of Annual General Meeting/Proxy Form		05/10/21	829.07KB	Share
PAB	Company Overview Presentation - September 2021		28/09/21	4.68MB	Share
PAB	Patrys to Present at Lifesciences Webinar		27/09/21	116.24KB	Share
PAB	PAT-DX3 proof of concept as potential ADC targeting antibody	PRICE SENSITIVE	15/09/21	302.49KB	Share
PAB	Change of Director's Interest Notice		06/09/21	129.93KB	Share
PAB	Application for quotation of securities - PAB		02/09/21	31.65KB	Share
PAB	Section 708A Cleansing Statement		02/09/21	209KB	Share
PAB	Appendix 4G and Corporate Governance Statement		25/08/21	705.51KB	Share
PAB	Appendix 4E and 2021 Annual Report	PRICE SENSITIVE	25/08/21	3.39MB	Share
PAB	Market Update - PAT-DX1 Clinical Trial Preparation	PRICE SENSITIVE	03/08/21	146.08KB	Share
PAB	Appendix 4C - Quarterly - 30 June 2021	PRICE SENSITIVE	29/07/21	345.35KB	Share
PAB	Change in substantial holding		28/07/21	2.23MB	Share
PAB	PAT-DX1 Improves Survival in Model of Pancreatic Cancer	PRICE SENSITIVE	26/07/21	202.8KB	Share
PAB	Full size deoxymab PAT-DX3 crosses the blood brain barrier	PRICE SENSITIVE	12/07/21	164.63KB	Share
PAB	Application for quotation of securities - PAB		02/07/21	27.52KB	Share
PAB	Section 708A Cleansing Statement		02/07/21	189.38KB	Share
PAB	Response to ASX Query	PRICE SENSITIVE	24/06/21	282.28KB	Share
PAB	Paper highlights PAT-DX1 as potential brain cancer treatment	PRICE SENSITIVE	16/06/21	326.04KB	Share
PAB	Patrys receives R&D Tax Incentive refund	PRICE SENSITIVE	10/06/21	161.19KB	Share
PAB	Shareholder Newsletter - June 2021		07/06/21	1.05MB	Share
PAB	Patrys and Imagion collaborate on new cancer imaging agents		03/05/21	169.62KB	Share
PAB	S708A Cleansing Notice and Appendix 2A		28/04/21	546.59KB	Share
PAB	Appendix 4C - Quarterly - 31 March 2021	PRICE SENSITIVE	28/04/21	381.84KB	Share
PAB	Patrys completes PAT-DX1 and PAT-DX3 pharmacokinetic studies		22/04/21	146.85KB	Share
PAB	New United States patent granted for Patrys' deoxymab assets	PRICE SENSITIVE	31/03/21	194.5KB	Share
PAB	S708A Cleansing Notice and Appendix 2A		03/03/21	581.18KB	Share
PAB	Appendix 4D - Half Year Accounts - 31 December 2020	PRICE SENSITIVE	19/02/21	748.01KB	Share
PAB	Appendix 2A		17/02/21	289.94KB	Share
PAB	Patrys Successfully Establishes PAT-DX1 Stable Cell Line	PRICE SENSITIVE	10/02/21	125.16KB	Share
PAB	Appendix 4C - Quarterly - 31 December 2020	PRICE SENSITIVE	28/01/21	203.68KB	Share
PAB	Change of Director's Interest Notices x5		23/12/20	402.44KB	Share
PAB	Change in substantial holding		22/12/20	902.4KB	Share
PAB	S708A Cleansing Notice and Appendix 2A		21/12/20	369.31KB	Share
PAB	Appendix 3G		21/12/20	295.63KB	Share
PAB	Appendix 3G		18/12/20	132.85KB	Share
PAB	Change of Director's Interest Notices x2		18/12/20	291.17KB	Share
PAB	Appendix 2A - Options		17/12/20	164.46KB	Share
PAB	Appendix 2A - Shares		17/12/20	163.93KB	Share
PAB	Issue of Shortfall Securities		17/12/20	119.8KB	Share
PAB	S708A Cleansing Notice		15/12/20	143.63KB	Share
PAB	Appendix 2A - Options		15/12/20	244.15KB	Share
PAB	Appendix 2A - Shares		15/12/20	165.04KB	Share
PAB	Issue of Securities under Entitlement Offer		15/12/20	122.35KB	Share
PAB	Entitlement Offer Results and Shortfall Notification		11/12/20	172.94KB	Share
PAB	Poster Presentation at San Antonio Breast Cancer Symposium		11/12/20	149.6KB	Share
PAB	Market update		03/12/20	130.02KB	Share
PAB	Amended Constitution		20/11/20	818.32KB	Share
PAB	Results of Annual General Meeting		19/11/20	191.29KB	Share
PAB	Chairman's Address and CEO Presentation to 2020 AGM		19/11/20	8.87MB	Share
PAB	Dispatch of Offer Letter to Eligible Shareholders		17/11/20	121.15KB	Share
PAB	S708A Cleansing Notice and Appendix 2A		16/11/20	295.86KB	Share
PAB	Update to Indicative Timetable for Entitlement Offer		11/11/20	128.17KB	Share
PAB	Letter to Ineligible Shareholders		09/11/20	64.8KB	Share
PAB	Letter to Option holders - Entitlement Offer		09/11/20	70.22KB	Share
PAB	Letter to Eligible Shareholders - Entitlement Offer		09/11/20	102.83KB	Share
PAB	Entitlement Offer Prospectus	PRICE SENSITIVE	09/11/20	390.61KB	Share
PAB	Proposed issue of Securities - PAB		09/11/20	45.27KB	Share
PAB	$7.3M Capital Raising	PRICE SENSITIVE	09/11/20	147.87KB	Share
PAB	Investor Presentation - November 2020 - Updated	PRICE SENSITIVE	05/11/20	11.32MB	Share
PAB	Investor Presentation - November 2020	PRICE SENSITIVE	05/11/20	1.46MB	Share
PAB	Trading Halt	PRICE SENSITIVE	05/11/20	200.12KB	Share
PAB	Appendix 4C - Quarterly - 30 September 2020	PRICE SENSITIVE	26/10/20	237.83KB	Share
PAB	Response to ASX Price Query	PRICE SENSITIVE	23/10/20	225.68KB	Share
PAB	Notice of Annual General Meeting/Proxy Form		19/10/20	565.47KB	Share
PAB	Change of Director's Interest Notice		12/10/20	81.39KB	Share
PAB	S708A Cleansing Notice and Appendix 2A		12/10/20	365.05KB	Share
PAB	First patent granted for Deoxymab-nanoparticles	PRICE SENSITIVE	06/10/20	231.93KB	Share
PAB	Patrys adds full human antibody to Deoxymab portfolio	PRICE SENSITIVE	28/09/20	276.67KB	Share
PAB	Response to ASX Price Query	PRICE SENSITIVE	15/09/20	224.67KB	Share
PAB	PAB Business Review - 30 June 2020		27/08/20	1.44MB	Share
PAB	Appendix 4G and Corporate Governance Statement		25/08/20	505.24KB	Share
PAB	Appendix 4E and 2020 Annual Report	PRICE SENSITIVE	25/08/20	1.13MB	Share
PAB	Change of Director's Interest Notices x2		07/08/20	387.73KB	Share
PAB	Change in substantial holding		07/08/20	828.73KB	Share
PAB	Appendix 2A - Options		05/08/20	222.99KB	Share
PAB	Appendix 2A - Shares		05/08/20	156.97KB	Share
PAB	Issue of Securities under Entitlement Offer		05/08/20	143.16KB	Share
PAB	Entitlement Offer Results and Shortfall Notification		03/08/20	170.67KB	Share
PAB	Appendix 4C - Quarterly - 30 June 2020	PRICE SENSITIVE	30/07/20	237.92KB	Share
PAB	Investor update		22/07/20	976.77KB	Share
PAB	Entitlement Offer Website Information		17/07/20	113.29KB	Share
PAB	Notice of Initial Substantial Holder		15/07/20	129.23KB	Share
PAB	Grant/alliance with Olivia Newton-John Cancer Research Inst		13/07/20	233.72KB	Share
PAB	Dispatch of Offer Letter to Eligible Shareholders		07/07/20	110.62KB	Share
PAB	Letter to Ineligible Shareholders		22/06/20	64.69KB	Share
PAB	Letter to Option holders - Entitlement Offer		22/06/20	64.28KB	Share
PAB	Letter to Eligible Shareholders - Entitlement Offer		22/06/20	97.42KB	Share
PAB	Entitlement Offer Prospectus	PRICE SENSITIVE	22/06/20	408.76KB	Share
PAB	Proposed issue of Securities - PAB		22/06/20	33.84KB	Share

PAB Chairman's Address and CEO Presentation to 2021 AGM
05/11/21		1.2MB	Share
PAB Application for quotation of securities - PAB
04/11/21		24.75KB	Share
PAB Letter to Optionholders - Entitlement Offer
01/11/21		192.97KB	Share
PAB Notice under Section 708AA(2)(F) - Entitlement Offer
01/11/21		208.7KB	Share
PAB Investor Presentation
01/11/21		5.06MB	Share
PAB Proposed issue of securities - PAB
01/11/21		38.75KB	Share
PAB $7.8M Capital Raising
01/11/21	PRICE SENSITIVE	221.31KB	Share
PAB Change of Company Secretary
29/10/21		144.24KB	Share
PAB Trading Halt
28/10/21	PRICE SENSITIVE	252.57KB	Share
PAB Appendix 4C - Quarterly - 30 September 2021
20/10/21	PRICE SENSITIVE	399.01KB	Share
PAB Patrys proof of concept ADC significantly increases survival
18/10/21	PRICE SENSITIVE	268.44KB	Share
PAB Notice of Annual General Meeting/Proxy Form
05/10/21		829.07KB	Share
PAB Company Overview Presentation - September 2021
28/09/21		4.68MB	Share
PAB Patrys to Present at Lifesciences Webinar
27/09/21		116.24KB	Share
PAB PAT-DX3 proof of concept as potential ADC targeting antibody
15/09/21	PRICE SENSITIVE	302.49KB	Share
PAB Change of Director's Interest Notice
06/09/21		129.93KB	Share
PAB Application for quotation of securities - PAB
02/09/21		31.65KB	Share
PAB Section 708A Cleansing Statement
02/09/21		209KB	Share
PAB Appendix 4G and Corporate Governance Statement
25/08/21		705.51KB	Share
PAB Appendix 4E and 2021 Annual Report
25/08/21	PRICE SENSITIVE	3.39MB	Share
PAB Market Update - PAT-DX1 Clinical Trial Preparation
03/08/21	PRICE SENSITIVE	146.08KB	Share
PAB Appendix 4C - Quarterly - 30 June 2021
29/07/21	PRICE SENSITIVE	345.35KB	Share
PAB Change in substantial holding
28/07/21		2.23MB	Share
PAB PAT-DX1 Improves Survival in Model of Pancreatic Cancer
26/07/21	PRICE SENSITIVE	202.8KB	Share
PAB Full size deoxymab PAT-DX3 crosses the blood brain barrier
12/07/21	PRICE SENSITIVE	164.63KB	Share
PAB Application for quotation of securities - PAB
02/07/21		27.52KB	Share
PAB Section 708A Cleansing Statement
02/07/21		189.38KB	Share
PAB Response to ASX Query
24/06/21	PRICE SENSITIVE	282.28KB	Share
PAB Paper highlights PAT-DX1 as potential brain cancer treatment
16/06/21	PRICE SENSITIVE	326.04KB	Share
PAB Patrys receives R&D Tax Incentive refund
10/06/21	PRICE SENSITIVE	161.19KB	Share
PAB Shareholder Newsletter - June 2021
07/06/21		1.05MB	Share
PAB Patrys and Imagion collaborate on new cancer imaging agents
03/05/21		169.62KB	Share
PAB S708A Cleansing Notice and Appendix 2A
28/04/21		546.59KB	Share
PAB Appendix 4C - Quarterly - 31 March 2021
28/04/21	PRICE SENSITIVE	381.84KB	Share
PAB Patrys completes PAT-DX1 and PAT-DX3 pharmacokinetic studies
22/04/21		146.85KB	Share
PAB New United States patent granted for Patrys' deoxymab assets
31/03/21	PRICE SENSITIVE	194.5KB	Share
PAB S708A Cleansing Notice and Appendix 2A
03/03/21		581.18KB	Share
PAB Appendix 4D - Half Year Accounts - 31 December 2020
19/02/21	PRICE SENSITIVE	748.01KB	Share
PAB Appendix 2A
17/02/21		289.94KB	Share
PAB Patrys Successfully Establishes PAT-DX1 Stable Cell Line
10/02/21	PRICE SENSITIVE	125.16KB	Share
PAB Appendix 4C - Quarterly - 31 December 2020
28/01/21	PRICE SENSITIVE	203.68KB	Share
PAB Change of Director's Interest Notices x5
23/12/20		402.44KB	Share
PAB Change in substantial holding
22/12/20		902.4KB	Share
PAB S708A Cleansing Notice and Appendix 2A
21/12/20		369.31KB	Share
PAB Appendix 3G
21/12/20		295.63KB	Share
PAB Appendix 3G
18/12/20		132.85KB	Share
PAB Change of Director's Interest Notices x2
18/12/20		291.17KB	Share
PAB Appendix 2A - Options
17/12/20		164.46KB	Share
PAB Appendix 2A - Shares
17/12/20		163.93KB	Share
PAB Issue of Shortfall Securities
17/12/20		119.8KB	Share
PAB S708A Cleansing Notice
15/12/20		143.63KB	Share
PAB Appendix 2A - Options
15/12/20		244.15KB	Share
PAB Appendix 2A - Shares
15/12/20		165.04KB	Share
PAB Issue of Securities under Entitlement Offer
15/12/20		122.35KB	Share
PAB Entitlement Offer Results and Shortfall Notification
11/12/20		172.94KB	Share
PAB Poster Presentation at San Antonio Breast Cancer Symposium
11/12/20		149.6KB	Share
PAB Market update
03/12/20		130.02KB	Share
PAB Amended Constitution
20/11/20		818.32KB	Share
PAB Results of Annual General Meeting
19/11/20		191.29KB	Share
PAB Chairman's Address and CEO Presentation to 2020 AGM
19/11/20		8.87MB	Share
PAB Dispatch of Offer Letter to Eligible Shareholders
17/11/20		121.15KB	Share
PAB S708A Cleansing Notice and Appendix 2A
16/11/20		295.86KB	Share
PAB Update to Indicative Timetable for Entitlement Offer
11/11/20		128.17KB	Share
PAB Letter to Ineligible Shareholders
09/11/20		64.8KB	Share
PAB Letter to Option holders - Entitlement Offer
09/11/20		70.22KB	Share
PAB Letter to Eligible Shareholders - Entitlement Offer
09/11/20		102.83KB	Share
PAB Entitlement Offer Prospectus
09/11/20	PRICE SENSITIVE	390.61KB	Share
PAB Proposed issue of Securities - PAB
09/11/20		45.27KB	Share
PAB $7.3M Capital Raising
09/11/20	PRICE SENSITIVE	147.87KB	Share
PAB Investor Presentation - November 2020 - Updated
05/11/20	PRICE SENSITIVE	11.32MB	Share
PAB Investor Presentation - November 2020
05/11/20	PRICE SENSITIVE	1.46MB	Share
PAB Trading Halt
05/11/20	PRICE SENSITIVE	200.12KB	Share
PAB Appendix 4C - Quarterly - 30 September 2020
26/10/20	PRICE SENSITIVE	237.83KB	Share
PAB Response to ASX Price Query
23/10/20	PRICE SENSITIVE	225.68KB	Share
PAB Notice of Annual General Meeting/Proxy Form
19/10/20		565.47KB	Share
PAB Change of Director's Interest Notice
12/10/20		81.39KB	Share
PAB S708A Cleansing Notice and Appendix 2A
12/10/20		365.05KB	Share
PAB First patent granted for Deoxymab-nanoparticles
06/10/20	PRICE SENSITIVE	231.93KB	Share
PAB Patrys adds full human antibody to Deoxymab portfolio
28/09/20	PRICE SENSITIVE	276.67KB	Share
PAB Response to ASX Price Query
15/09/20	PRICE SENSITIVE	224.67KB	Share
PAB PAB Business Review - 30 June 2020
27/08/20		1.44MB	Share
PAB Appendix 4G and Corporate Governance Statement
25/08/20		505.24KB	Share
PAB Appendix 4E and 2020 Annual Report
25/08/20	PRICE SENSITIVE	1.13MB	Share
PAB Change of Director's Interest Notices x2
07/08/20		387.73KB	Share
PAB Change in substantial holding
07/08/20		828.73KB	Share
PAB Appendix 2A - Options
05/08/20		222.99KB	Share
PAB Appendix 2A - Shares
05/08/20		156.97KB	Share
PAB Issue of Securities under Entitlement Offer
05/08/20		143.16KB	Share
PAB Entitlement Offer Results and Shortfall Notification
03/08/20		170.67KB	Share
PAB Appendix 4C - Quarterly - 30 June 2020
30/07/20	PRICE SENSITIVE	237.92KB	Share
PAB Investor update
22/07/20		976.77KB	Share
PAB Entitlement Offer Website Information
17/07/20		113.29KB	Share
PAB Notice of Initial Substantial Holder
15/07/20		129.23KB	Share
PAB Grant/alliance with Olivia Newton-John Cancer Research Inst
13/07/20		233.72KB	Share
PAB Dispatch of Offer Letter to Eligible Shareholders
07/07/20		110.62KB	Share
PAB Letter to Ineligible Shareholders
22/06/20		64.69KB	Share
PAB Letter to Option holders - Entitlement Offer
22/06/20		64.28KB	Share
PAB Letter to Eligible Shareholders - Entitlement Offer
22/06/20		97.42KB	Share
PAB Entitlement Offer Prospectus
22/06/20	PRICE SENSITIVE	408.76KB	Share
PAB Proposed issue of Securities - PAB
22/06/20		33.84KB	Share

REFRESH

First 2 3 4 5 6

(20min delay)
Last 0.9¢		Change 0.000(0.00%)		Mkt cap ! $18.51M

Open	High	Low	Value	Volume
0.9¢	0.9¢	0.9¢	$18.68K	2.075M

Buyers (Bids)

No.	Vol.	Price($)
11	2642383	0.8¢

Sellers (Offers)

Price($)	Vol.	No.
0.9¢	856022	2

View Market Depth

No.	Vol.	Price($)
11	2642383	0.008
17	4746715	0.007
11	2787680	0.006
8	3144992	0.005
5	4324000	0.004

Price($)	Vol.	No.
0.009	856022	2
0.010	1830082	5
0.011	1380000	4
0.012	372407	3
0.013	990000	2

Last trade - 16.10pm 26/04/2024 (20 minute delay)


Last 0.9¢		Change 0.000 ( 0.00 %)
Open	High	Low	Volume
0.9¢	0.9¢	0.9¢	97616
Last updated 11.58am 26/04/2024 ?

PAB (ASX) Chart

PATRYS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available